Tissue transglutaminase antibodies

Anti-tTG IgA and IgG (atTg) are antibodies to tissue transglutaminase. Tissue transglutaminase is directly related to the pathogenesis of some diseases (celiac disease) and has been described as the endomysium's own chemical substrate. Tissue transglutaminase (transglutaminase II isoenzyme, TG2 - EC 2.3.2.13), is a transferase, and is also known as protein-glutamine γ-glutamyltransferase. It is a Ca2+ dependent enzyme catalyzing the deamination of glutamine to glutamate and the intramolecular binding of glutamine to another primary amine, e.g., lysine, which results in the aggregation of glutamine peptides. The determination of antibodies to tissue transglutaminase (atTG) therefore also has a very high diagnostic efficiency, similar to antibodies against endomysium (sensitivity is 87-97% and specificity is 88-98%).

The determination of atTG is performed by the classical ELISA method, which is a technique more available for routine diagnostics than immunofluorescence detection of anti-endomysium antibodies (EmA).

Unlike EmA, atTG antibodies can be found as IgA and IgG, which is important for patients with selective IgA deficiency. Older kits used guinea pig antigens. Newer kits use tissue transglutaminase isolated from human cells, human erythrocytes, or recombinant tTG isolated from E. coli. The reference values ​​differ for individual kits with the upper limit of the physiological range usually being 10–15 IU / l for IgA antibodies (some kits also define a so-called gray-zone in the range of 10-20 IU / l). Determination of atTG antibodies with human recombinant antigen shows lower false positivity than guinea pig antigen methods. Recent studies compare IgA and IgG antibodies and POCT methodologies for the determination of atTG antibodies.

The determination of atTG antibodies in the IgA class is recommended as a basic screening test for the diagnosis of celiac disease.

Source

 * With the permission of the author, taken from KOCNA, Petr. GastroLab: MiniEncyclopedia of laboratory methods in gastroenterology  [online]. © 2002. Last revision 2011-01-08, [cit. 2011-03-04]. < http://www1.lf1.cuni.cz/~kocna/glab/glency1.htm >.

Literature

 * BAVIERA, LC, et al. Celiac disease screening by immunochromatographic visual assays: results of a multicenter study. J Pediatr Gastroenterol Nutr. 2007, vol. 45, no. 5, s. 546-50, ISSN 0277-2116 (Print), 1536-4801 (Electronic). PMID: 18030231.


 * SÁRDY, M, et al. Tissue transglutaminase ELISA positivity in autoimmune disease independent of gluten-sensitive disease. Clin Chim Acta. 2007, vol. 376, no. 1-2, s. 126-35, ISSN 0009-8981 (Print), 1873-3492 (Electronic). PMID: 16987503.


 * BYRNE, G, et al. Mutagenesis of the catalytic triad of tissue transglutaminase abrogates coeliac disease serum IgA autoantibody binding. Gut. 2006, vol. 56, no. 3, s. 336-41, ISSN 0017-5749 (Print), 1468-3288 (Electronic). PMID: 16935926.


 * RAIVIO, T, et al. Self transglutaminase-based rapid coeliac disease antibody detection by a lateral flow method. Aliment Pharmacol Ther. 2006, vol. 24, no. 1, s. 147-54, ISSN 0269-2813 (Print), 1365-2036 (Electronic). PMID: 16803613.


 * BARKER, CC, et al. Can tissue transglutaminase antibody titers replace small-bowel biopsy to diagnose celiac disease in select pediatric populations?. Pediatrics. 2005, vol. 115, no. 5, s. 1341-6, ISSN 0031-4005 (Print), 1098-4275 (Electronic). PMID: 15867045.


 * MANKAÏ, A, et al. Tissue transglutaminase antibodies in celiac disease, comparison of an enzyme linked immunosorbent assay and a dot blot assay. Pathol Biol (Paris). 2005, vol. 53, no. 4, s. 204-9, ISSN 0369-8114 (Print), 1768-3114 (Electronic). PMID: 15850953.


 * BAUDON, JJ, et al. Diagnosing celiac disease: a comparison of human tissue transglutaminase antibodies with antigliadin and antiendomysium antibodies. Arch Pediatr Adolesc Med. 2004, vol. 158, no. 6, s. 584-8, ISSN 1072-4710 (Print), 1538-3628 (Electronic). PMID: 15184223.


 * FERRE-LÓPEZ, S, et al. Immunochromatographic sticks for tissue transglutaminase and antigliadin antibody screening in celiac disease.. Clin Gastroenterol Hepatol. 2004, vol. 2, no. 6, s. 480-4, ISSN 1542-3565 (Print), 1542-7714 (Electronic). PMID: 15181616.


 * Tommasini A. - Arch Dis Child. 2004, 15155392. Mass screening for coeliac disease using antihuman transglutaminase antibody assay. Arch Dis Child. 2004, vol. 89, no. 6, s. 512-5, ISSN 0003-9888 (Print), 1468-2044 (Electronic). PMID: 15155392.


 * SINCLAIR, D, et al. A comparative study of tissue transglutaminase antibodies and endomysium antibody immunofluorescence in routine clinical laboratory practice. Ann Clin Biochem. 2003, vol. 40, s. 411-6, ISSN 0004-5632 (Print), 1758-1001 (Electronic). PMID: 12880544.


 * TONUTTI, E, et al. The role of antitissue transglutaminase assay for the diagnosis and monitoring of coeliac disease: a French-Italian multicentre study. J Clin Pathol. 2003, vol. 56, no. 5, s. 389-93, ISSN 0021-9746 (Print), 1472-4146 (Electronic). PMID: 12719462.


 * KOCNA, P, et al. Tissue transglutaminase-serology markers for coeliac disease. Clin Chem Lab Med. 2002, vol. 40, no. 5, s. 485-92, ISSN 1434-6621. PMID: 12113293.


 * WOLTERS, V, et al. Human tissue transglutaminase enzyme linked immunosorbent assay outperforms both the guinea pig based tissue transglutaminase assay and anti-endomysium antibodies when screening for coeliac disease. Eur J Pediatr. 2002, vol. 161, no. 5, s. 284-7, ISSN 0340-6199 (Print), 1432-1076 (Electronic). PMID: 12012226.


 * HANSSON, T, et al. Recombinant human tissue transglutaminase for diagnosis and follow-up of childhood coeliac disease. Pediatr Res. 2002, vol. 51, no. 6, s. 700-5, ISSN 0031-3998 (Print), 1530-0447 (Electronic). PMID: 12032264.


 * CLEMENTE, MG, et al. Antitissue transglutaminase antibodies outside celiac disease. J Pediatr Gastroenterol Nutr. 2002, vol. 34, no. 1, s. 31-4, ISSN 0277-2116 (Print), 1536-4801 (Electronic). PMID: 11753161.


 * BARDELLA, MT, et al. Serological markers for coeliac disease: is it time to change?. Dig Liver Dis. 2001, vol. 33, no. 5, s. 426-31, ISSN 1590-8658 (Print), 1878-3562 (Electronic). PMID: 11529655.


 * BASSO, D, et al. Role of anti-transglutaminase (anti-tTG), anti-gliadin, and anti-endomysium serum antibodies in diagnosing celiac disease: a comparison of four different commercial kits for anti-tTG determination. J Clin Lab Anal. 2001, vol. 15, no. 3, s. 112-5, ISSN 0887-8013 (Print), 1098-2825 (Electronic). PMID: 11344524.


 * CHAN, AW, et al. Tissue transglutaminase enzyme-linked immunosorbent assay as a screening test for celiac disease in pediatric patients. Pediatrics. 2001, vol. 107, no. 1, s. E8, ISSN 0031-4005 (Print), 1098-4275 (Electronic). PMID: 11134472.


 * FABIANI, E, et al. The serum IgA class anti-tissue transglutaminase antibodies in the diagnosis and follow up of coeliac disease. Results of an international multi-centre study. International Working Group on Eu-tTG. Eur J Gastroenterol Hepatol. 2001, vol. 3, no. 6, s. 659-65, ISSN 0954-691X (Print), 1473-5687 (Electronic). PMID: 11434591.


 * LEON, F, et al. Anti-transglutaminase IgA ELISA: clinical potential and drawbacks in celiac disease diagnosis. Scand J Gastroenterol. 2001, vol. 36, no. 8, s. 849-53, ISSN 0036-5521 (Print), 1502-7708 (Electronic). PMID: 11495081.


 * KORDONOURI, O, et al. Autoantibodies to tissue transglutaminase are sensitive serological parameters for detecting silent coeliac disease in patients with Type 1 diabetes mellitus. Diabet Med. 2000, vol. 17, no. 6, s. 441-4, ISSN 0742-3071 (Print), 1464-5491 (Electronic). PMID: 10975212.